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Abstract Acetylcholine receptor-inducing activity (ARIA) is a 
glycoprotein initially purified from chick brain based on its 
ability to increase the synthesis of acetylcholine receptor (AChR) 
on cultured myotubes. cDNA encoding ARIA contains different 
domains and the functions of each domain in ARIA activity are 
not known. We used molecular genetic methods to construct a 
chimeric fusion protein, designated ARIAS136_K205-Fc, that 
contained the leader sequence, the EGF-like domain of chick 
ARIA (Si36 to K205) and the Fc region of human immunoglo-
bulin. The ARIAS136_K205-Fc cDNA was transfected into HEK 
293 cells and stable cell lines secreting soluble ARIAS136_K205-Fc 
were obtained. The secreted ARIASI36_K2OS-FC has a molecular 
mass of ~ 6 0 kDa and can be purified by protein G 
Chromatograph). The purified ARIAsl36_K2os-Fc retained its 
full biological activity of chick ARIA that included: (i) induction 
of tyrosine phosphorylation of erbB 3 receptor in C2C12 
myotubes; and (ii) ~ 12-fold stimulation of AChR a-subunit 
niRNA synthesis when applied onto cultured chick myotubes. 
This Fc-tagged ARIA could be rapidly purified and provides a 
very useful ligand for identifying its true receptor(s) on muscle 
cell surface. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
During the development of neuromuscular junctions, there 
occurs the formation of postsynaptic specializations directed 
by the motor neurons approaching the muscle fibers [1]. These 
postsynaptic specializations include the aggregation of acetyl-
choline receptors (AChRs), acetylcholinesterase (AChE) and 
other synaptic proteins [2]. The increase in postsynaptic 
AChR density, up to approx. 10000 receptors/urn2, is primar-
ily due to an increase in local AChR synthesis, and to the 
aggregation of AChRs already present in the membrane at 
the time of nerve-muscle contact [1,3]. 
In the local synthesis of post-synaptic molecules, RNAs 
encoding AChR subunits, AChE and other synapse specific 
proteins are highly concentrated in the synaptic regions [4—7]. 
The up-regulation of AChR synthesis at the neuromuscular 
junctions is induced by motor neurons. The motor nerve pro-
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vides two distinct mechanisms to achieve this striking local-
ization of AChRs: (i) axons release factors, like calcitonin 
gene-related peptide [8], ascorbic acid [9] and acetylcholine 
receptor inducing activity (ARIA) [10], that stimulate the syn-
aptic expression of AChR; and (ii) nerve-evoked electrical 
activity represses the synthesis of AChR in the extrasynaptic 
regions [11,12]. 
ARIA was first identified from chick brain and is the best 
candidate for the nerve-derived signal for such postsynaptic 
gene regulation. ARIA could mimic the effects of motor axons 
on the muscle target that include: inducing the synthesis of 
AChR in aneural myotubes [10], and increasing the number of 
voltage-gated sodium channels [13] and the expression of the 
e-subunit of AChR characteristic of the adult AChR [14-16]. 
In addition, ARIA was shown to stimulate the tyrosine phos-
phorylation of both erbB2 and erbB3, and the activation of 
mitogen-activated protein kinase indicating that ARIA's sig-
naling pathway in muscle might be mediated by erbB2 and/or 
erbB3 receptors [14-16]. Recent studies, however, indicate 
that the true receptor for ARIA could just heterodimerize 
and then phosphorylate either one of its homologous EGF-
like receptors, such as erbB2 and/or erbB3 [17]. Based on 
these observations, Loeb and Fischbach [18] proposed that 
ARIA is released from the developing motor nerve terminals, 
activates its receptor on the postsynaptic muscle membrane 
and thus induces postsynaptic gene expression at the neuro-
muscular junctions. 
cDNA encoding ARIA was first isolated from a X,gt 10 
chick brain library. Sequencing analysis has revealed that 
ARIA is a member of a growing family of regulatory factors, 
named the neuregulin family, which are derived from the same 
gene by alternative RNA splicing [15,19]. Several members of 
this family have been identified: neu differentiation factor 
from rat (NDF) [20], heregulin from human [21] and glial 
growth factor from bovine (GGF) [19]. The cloned ARIA 
cDNA encoded for a considerably larger transmembrane pre-
cursor denoted pro-ARIA with a predicted protein of 602 
amino acids. From the N-terminus to the C-terminus, pro-
ARIA has immunoglobulin (Ig)-like, epidermal growth factor 
(EGF)-like, hydrophobic and intracellular domains [22]. Ma-
ture ARIA, which is 42 kDa in size, is believed to be a prod-
uct after proteolytic cleavage of pro-ARIA at the dibasic ami-
no acid residues (K205 and R206) adjacent to the hydrophobic 
domain [22,23]. The N-terminus containing Ig-like domain is 
able to bind to the extracellular matrix through charged in-
teractions at the synaptic clefts [18]. The EGF-like domain 
can be released by unknown proteases and acts on the post-
synaptic muscle membrane. The EGF-like domain derived 
from other members of neuregulin has been shown to induce 
the tyrosine phosphorylation of erbB receptors and the induc-
tion of AChR expression [15,16,18]. In order to support the 
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' A R I A release' hypothesis and to create a ligand for receptor 
identification, we constructed a protein fragment of A R I A 
containing only the EGF-like domain tagged with Fc region 
of human Ig, namely ARIAsi36-K205-Fc. The Fc-tagged A R I A 
fusion protein was functionally expressed in mammalian cells 
and the fusion protein could be purified by protein G column. 
The purified ARIAsi36-K205-Fc shows full biological activity 
of A R I A in the induction of erbB3 receptor tyrosine phos-
phorylation and an increase in the expression of m R N A en-
coding muscle A C h R a-subunit . 
2. Materials and methods 
2.1. cDNA construction and transfection 
The leader sequence from hemagglutinin of the avian influenza 
virus FPV was purified from the expression vector of pM4-3, and 
this leader sequence was inserted into a mammalian expression vector 
pcDNA I (Invitrogen, San Diego, USA) as described in [24]. Down-
stream of the leader sequence was a cloning site EcoRl of the pcDNA 
I, followed by a ~ 0.6 kb cDNA fragment encoding the Fc region of 
human immunoglobulm Gl . The EGF-like domain of ARIA was 
constructed by PCR with a pair of primers flanking S136 to K205, 
with an artificial EcoRl site at both ends, according to the published 
sequence of pro-ARI A [22]. The standard reaction mixture contained 
chick pro-ARIA cDNA, 2.5 units of Vent DNA polymerase and 0.3 
ug of forward primer: 5' CGG AAT TCC AGT CAT CTC ACA 
AAA 3' (sense, 435^149); and backward primer: 5' CTG AAT TCT 
TTC TGG TAC AGT TCC 3' (anti-sense, 628-643). The reaction 
mixture was subjected to PCR under the following conditions: 1 min 
denaturation at 94°C, 1 min annealing at 55°C and 1 min elongation 
at 72°C for 30 cycles with 10 min of extension at 72°C at the last 
cycle. The PCR product was digested with ücoRI and purified on 
silica gel (Geneclean II kit, BIO 101, USA); the DNA fragment 
was subcloned into the EcoRl site of the modified pcDNA I vector 
as shown in Fig. 1. The ARIAsi36-K205 DNA fragment was confirmed 
to be in-frame with the leader sequence at the 5' end and human Ig Fc 
at the 3' end by DNA sequence analysis with a Sequenase 2.0 kit 
(USB, OH, USA). The modified pcDNA I containing the 
ARIAsi36-K205-Fc cDNA fragment was transfected into the human 
embryonic kidney fibroblast cell line, HEK 293, by the calcium phos-
phate method as described [25]. The stably transfected cells were se-
lected by co-transfecting a G418 resistance gene followed by the use of 
antibiotic G418 (Gibco Laboratories, NY, USA) and flow cytometry 
for single cell cloning. 
2.2. Purification of ARIAsiw-K205-Fc fusion protein 
Protein G agarose (Boehringer Mannhein, Germany) was in a 1:1 
volume, pre-washed twice with 0.1 M glycine pH 3.0 and then with 
phosphate-buffered saline (PBS; 80 inM Na 2HP0 4 , 20 mM 
NaH 2P0 4 , 100 mM NaCl, pH 8.0). About 0.5 ml of protein G agar-
ose beads were mixed with 50 ml conditioned medium from 
ARIAS136_K205-Fc cDNA transfected HEK 293 cells, buffered with 
10 mM Tris and 1 mM phenylmethylsulfonyl fluoride (PMSF). The 
mixture was rotated at 4°C for 2 h, and then the beads was centri-
fuged down. The beads were transferred to an Eppendoff tube and 
washed 3 times with PBS pH 8.O. The ARIAsi36-K205-Fc fusion pro-
tein was eluted using 0.1 M glycine pH 3.0 and then neutralized with 
1/10 volume of 1 M Tris-HCl pH 8.O. The purified protein was stored 
at -80°C until further use. 
2.3. Muscle cell cultures 
For primary chick myotube cultures, hind-limb muscles dissected 
from 11-day-old New Hampshire chick embryos were dissociated ac-
cording to the method of Fischbach [26] with minor modifications 
[27]. Muscle cells were routinely cultured in MEM supplemented 
with 10% heat-inactivated horse serum, 2% chick embryo extract, 
1 mM L-glutamine, 100 U/ml penicillin and 100 ug/ml streptomycin. 
C2C12 myoblasts were maintained in DMEM supplemented with 10% 
heat inactivated horse serum, 1 mM L-glutamine, 100 U/ml penicillin 
and 100 ug/ml streptomycin. C2C12 myoblasts were induced to fuse at 
confluent stages by serum starvation to 2% finally. The AChR-induc-
ing activity assay was performed on 4-day-old chick muscle cultures, 
J.F. Yang et al.lFEBS Letters 403 (1997) 163-167 
and treatment of ARIA or tetrodotoxin (TTX) was carried out over-
night. 
2.4. Immunochemical analysis 
In phosphorylation studies, fused C2C12 myotubes were treated 
with purified recombinant ARIAsi36-K206-Fc for 30 min. Treated cells 
were lysed in RIPA buffer (PBS pH 7.4, 1% NP-40, 0.5% dexocox-
ylate, 0.1% SDS, 1 mM PMSF, 1 mM orthovanadate, 1 mM aproti-
nin). The erbB3 receptor was immunoprecipitated with a rabbit anti-
body against erbB3 (C17; Santa Cruz Bitotech. CA, USA) at 1:1000 
dilution. Immunoprecipated proteins were collected on protein G 
agarose beads, and fractionated on 7.5% SDS-PAGE. Electrophor-
esed proteins were transferred onto nitrocellulose membrane (MSI, 
MA, USA) as described in [25]. The membrane was blocked with 
2.5% dry milk containing 20 mM Tris HC1, pH 7.6, 137 mM NaCl, 
0.1% Tween 20, for 1 h at 37°C, followed by incubation with horse-
radish peroxidase-conjugated anti-tyrosine phosphorylation antibod-
ies RC 20 (Transduction Lab., USA) diluted 1:1000. Immunoreactiv-
ity was detected on an ECL Western Blot System (Amersham, UK) 
following the instructions of the supplier. 
For histochemical staining, the ARIAsi36-K205-Fc C D N A trans-
fected HEK 293 cells were washed with PBS and fixed for 10 min 
at room temperature with PBS, pH 7.4, containing 2% paraformalde-
hyde, 5% sucrose. Cells were permeabilized for 3 min with 0.1% Tri-
ton X-100 in PBS followed by washing 3 times in PBS. Cells were then 
incubated with peroxidase-conjugated protein A diluted 1:5000 in 
PBS with 10% fetal calf serum for 3 h at room temperature. The cells 
were washed 3 times with PBS, and the peroxidase activity was de-
veloped in diaminobenzidine for 30 min with a Zymed liquid DAB-
black substrate kit. The cells were washed with PBS and mounted 
with glycerol. Labeled cells were visualized under a Zeiss Axiophot 
microscope. 
2.5. Northern blot analysis of AChR a-subunit 
Total RNA was collected from treated chick myotubes using the 
guanidium thiocyanate method [28]. Total RNA was electrophoresed 
in an 1% formaldehyde-agarose gel, transferred overnight onto a ny-
lon membrane (MSI) and hybridized with a cDNA probe of ~ 1.2 kb 
chick AChR a-subunit [5]. Probes were labeled by the random oligo-
nucleotide priming method using [oc-32P]dCTP (Amersham) with a 
commercially available labeling kit (Pharmacia, Sweden). Hybridiza-
tion was performed at 42°C overnight in 50% formamide, 6XSSC, 
Fig. 1. cDNA encodes ARIAsi36-K205-Fc. The signal sequence (S S) 
from hemagglutinin of the avian influenza virus FPV was inserted 
into a mammalian expression vector pcDNA I with a downstream 
EcoRl site followed by a ~0 .6 kb cDNA fragment encoding Fc re-
gion of human immunoglobulin Gl (Ig Fc). The EGF-like domain 
of ARIA was created by PCR with a pair of primers flanking Si36 
to K205, with an artificial &oRI site at both ends, and subcloned 
between the signal sequence and Ig Fc. The integrity of the con-
struct was confirmed by DNA sequencing, and the DNA was used 
for transfection analysis. 
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Fig. 2. HEK 293 cells transfected with ARIASi36-K205-Fc CDNA ex-
pressed human Ig proteins. Transfected 293 cells were washed, fixed 
and permeabilised with 0.1% Triton X-100 in PBS followed by 
washing in PBS. Cells were then incubated with peroxidase-conju-
gated protein A for 3 h at room temperature. The peroxidase activ-
ity was developed in diaminobenzidine with a Zymed liquid DAB-
black substrate kit. The labeled cells were visualized under Zeiss Ax-
iophot microscopy. (A) Transient transfection of ARIAsi36-K205-Fc 
cDNA for 24 h had about 30% of cells showed peroxidase staining. 
(B) Stable transfected cells were selected by antibiotic and single cell 
cloning, and all the cells showed peroxidase staining. Scale bar, 80 
um. 
5xDenhart's solution, 0.1% SDS, 10% dextran sulfate, and 100 ug/ml 
denatured salmon sperm DNA. After hybridization, filters were 
washed with decreasing concentrations of SSC to a final concentration 
of 0.1 X SSC with 0.1% SDS at 55°C, and exposed to X-ray film with 
intensifying screens at —80°C. 
3. Results 
The cDNA encoding ARIAsi36-K205-Fc fusion protein was 
constructed and subcloned into pcDNA I with an artificial 
leader sequence as in Fig. 1. The ARIASI36-K205-FC C D N A 
in pcDNA I was purified and transfected into HEK 293 cells 
by the calcium phosphate method. After 2 days of transfec-
tion, the cells were fixed and stained with peroxidase-conju-
gated protein A. About 30% of cells showed positive staining 
of peroxidase-conjugated protein A (Fig. 2A). Stable trans-
fectants were selected by antibiotic and flow cytometry. The 
selected HEK 293 cells, as determined using peroxidase-con-
jugated protein A, show the expression of ARIAsi36-K205-Fc 
fusion protein (Fig. 2B). A clonai cell line was obtained. Be-
cause of the artificial signal sequence, ARIAsi36-K205-Fc from 
cultured stably transfected HEK 293 cells was secreted into 
the conditioned medium. When the conditioned medium was 
loaded onto SDS gels for immunoblotting analysis, a predom-
inant protein band at ~ 6 0 kDa was recognized by anti-hu-
man Ig Fc antibody (Fig. 3, lane 1). The ARIAsi36-K205~ Fc 
could be purified by protein G affinity chromatography. Con-
ditioned medium of stably transfected HEK 293 cells was 
collected and recirculated onto a protein G column, the 
bound protein being eluted with low pH buffer. The purified 
ARIAsi36-K205-Fc protein demonstrated a protein band at 
~ 6 0 kDa on a Coomassie stained SDS gel (Fig. 3, lane 2). 
The molecular mass of ARIAsi36-K205-Fc protein remained 
unchanged before and after protein G purification, indicating 
the integrity of the recombinant protein (compare Fig. 3, lanes 
1,2). The identity of the purified protein was further confirmed 
by its recognition of anti-human Ig Fc antibody, and with 
anti-ARIA polyclonal antibody (Fig. 3, lanes 3,4). In general, 
over 20 ug of fusion protein from 100 ml of conditioned 
medium could be purified by protein G chromatography 
and this only required 4 h. The predicted size of 
ARIAsi36-K205-Fc protein from its cDNA is ~ 4 0 kDa; the 
larger size of the recombinant ARIAgi36-K205-Fc protein ob-
served could be the result of heavy glycosylation in the fusion 
protein, and the likelihood is that it is at the human Ig Fc 
region, since the size of human Ig Fc alone is almost the same 
as that of ARIAsi36-K205-Fc (Fig. 3, lane 5). When similar 
expression analysis was performed on a full-length ARIA 
molecule (from K44 to K205) that contained an Ig-like domain, 
Fig. 3. Expression and purification of ARIAsi36-K205-Fc from trans-
fected HEK 293 cells. Samples were loaded onto a 10% polyacryl-
amide gel, and some of them were transferred onto a nitrocellulose 
paper for the recognition by antibodies. Lanes: 1, conditioned me-
dium from ARIAsi36_K205-Fc cDNA stable transfected HEK 293 
cells and probed with anti-human Ig antibody conjugated with per-
oxidase in a Western blot analysis; 2, about 3 ug of protein G puri-
fied ARIAsi36-K205-Fc was analyzed by SDS gel electrophoresis and 
stained with Coomassie blue; 3, about 0.1 ug of protein G purified 
ARIAsi36-K205-Fc was recognized by anti-human Ig antibody; 4, 
about 0.1 ug °f purified ARIAs136_K205-Fc was recognized by anti-
ARIA antibody on a western blot analysis. The production of anti-
ARIA antibody is described elsewhere; 5, about 0.1 ug of purified 
human Ig Fc fragment from Fc cDNA transfected cells and recog-
nized by peroxidase-conjugated anti-human Ig antibody; 6, condi-
tioned medium of HEK 293 cells transfected with full-length ARIA 
cDNA containing Ig-like domain, EGF-like domain and tagged 
with human Ig Fc. The protein band was recognized by peroxidase-
conjugated anti-human Ig antibody. Molecular markers are in kDa. 
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an EGF-like domain and was tagged with human Ig Fc, a 
similar size of ~ 6 0 kDa fusion protein was obtained (Fig. 
3, lane 6). This indicates that a potential cleavage site exists 
between the Ig-like and EGF-like domains of ARIA, and the 
release of active EGF-like fragment could be a prerequisite for 
its functions. 
The biological activity of ARIAgi36-K205-Fc protein was 
confirmed by its induction of tyrosine phosphorylation and 
stimulation of the synthesis of AChR a-subunit in cultured 
myotubes. Application of ARIAsi36-K205-Fc induced the 
phosphorylation of erbB 3 receptor in C2C12 myotube cul-
tures (Fig. 4), that was similar to the activity of full-length 
recombinant ARIA previously described [6,15,23]. Both 
ARIA and ARIAsi36_K205-Fc induced tyrosine phosphoryla-
tion of a protein with a molecular mass of —185 kDa. The 
identity of the phosphorylated protein was confirmed by its 
recognition with anti-erbB 3 receptor antibody indicating the 
specific induction of erbB 3 phosphorylation by ARIA in 
C2C12 myotubes (Fig. 4). The purified ARIASI36-K205-FC pro-
tein was able to stimulate the synthesis of mRNA encoding 
the AChR a-subunit of cultured chick myotubes. A transcript 
size of ~3 .2 kb was detected by using an AChR a-subunit 
cDNA probe (Fig. 5). The expression of AChR a-subunit 
mRNA in cultured chick myotubes was increased to ~ 12-
fold after treatment of ARIASI36-K2OS-FC for 1 day, while 
TTX was used as a positive control and showed ~ 50-fold 
induction in AChR a-subunit mRNA expression. 
4. Discussion 
Our studies support the release hypothesis of ARIA that 
the EGF-like domain from S136 to K2o5 contains the full bio-
logical activity of chick ARIA in the induction of erbB3 re-
> 
Fig. 4. ARIAgi36_K205-Fc induced tyrosine phosphorylation of erbB 
3 on C2C12 myotubes. The C2C12 myotubes were treated with pu-
rified ARIAsi36-K205-Fc for 30 min. Treated cells were lysed in 
RIPA buffer. The erbB3 receptor was immunoprecipitated with 
1:1000 of a rabbit antibody (C17) against erbB3. The immunopre-
cipitated proteins were collected on protein G agarose beads and 
fractionated by 7.5% SDS-PAGE. Electrophoresed proteins were 
transferred onto nitrocellulose membrane, and detected by peroxi-
dase-conjugated anti-tyrosine phosphorylation antibodies RC 20 
(upper panel). The same filter was washed and probed with anti-
erbB 3 receptor antibody as to confirm the identity of the recog-
nized band (lower panel). Lanes: 1, control untreated myotubes; 2, 
recombinant full-length ARIA; 3, recombinant ARIASI36-K205-FC. 
Arrowheads indicate the molecular size of recognized proteins. 
Fig. 5. ARIAsi36-K205-Fc induced the synthesis of mRNA encoding 
AChR a-subunit. 4-day-old chick myotubes were treated overnight 
with ~ 3 u.g of purified ARIAsi36-K205-Fc (lane 2) or 1 u.M TTX 
(lane 3). The untreated myotube is the control (lane 1). Total RNA 
was isolated from the cells and 10 ug of RNA were subjected to 1% 
formaldehyde-agarose gel. The membrane was probed with AChR 
a-subunit cDNA (~1.2 kb), and a transcript of ~3.2 kb was de-
tected. ARIAs136_K205-Fc and TTX increased the AChR a-subunit 
mRNA ~12- and ~ 50-fold, respectively. Two independent experi-
ments showed similar mRNA induction. Lower panel shows the ri-
bosomal RNA staining with 18S and 28S as markers. 
ceptor phosphorylation and the increase of AChR a-subunit 
mRNA expression. Although we did not compare the potency 
of ARIAsi36-K205-Fc activity with full-length ARIA in our 
activity assay, the preliminary results from our transfection 
studies showed that their activity in AChR induction is very 
comparable (Yang et a l , unpublished results). In addition, 
when we expressed the full-length ARIA containing the Ig-
like domain, EGF-like domain and tagged with human Ig Fc, 
a protein size of ~ 6 0 kDa similar to that of ARIAsi36-K205-
Fc was obtained. This indicates that a protease cleavage site 
between the Ig-like and EGF-like domains of chick ARIA 
exists even in transfected fibroblasts; the release of the 
EGF-like fragment seems to be a prerequisite step for the 
AChR-inducing activity of ARIA. In our laboratory, we are 
creating different mutants at the region between the Ig-like 
and EGF-like domains so as to determine the exact cleavage 
site for the release of the active EGF-like fragment of ARIA. 
The exact mechanism for the release of the bioactive EGF-
like fragment from the ARIA molecule at the neuromuscular 
junctions is not known. According to the hypothesis proposed 
by Loeb and Fischbach [18], the motor neurons express pro-
ARIA in a transmembrane form, which is released into the 
synaptic cleft in the form of ARIA by protease cleavage at 
K205 and R206- The released ARIA binds to glycosaminogly-
cans at the synaptic cleft by charge interaction on the Ig-like 
domain. By further action of protease at the neuromuscular 
junctions, the biologically active EGF-like domain of ARIA is 
released, and activates a receptor on the postsynaptic muscle 
membrane in causing the up-regulation of AChR and other 
synaptic gene expression. Several lines of evidence support 
such a hypothesis: (i) an activity found to increase the local 
transcript of AChR subunits is associated with the basal lam-
ina of the neuromuscular junctions after axotomy [29,30]; (ii) 
the ARIA immunoreactivity is revealed to be localized at the 
synaptic basal lamina [15]; (iii) both glycosaminoglycan and 
proteases are commonly found in the synaptic cleft; and (iv) 
the Ig-like and EGF-like domains show activity in glycosami-
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noglycan binding and AChR induction, respectively ([18,31]; 
this study). Thus, the specific regulation of protease in the 
synaptic cleft could be a determining step in releasing the 
functional fragment of ARIA for AChR induction, and thus 
regulates the formation of neuromuscular junctions during 
development and nerve regeneration. However, one should 
bear in mind that the direct proof of this hypothesis has not 
been established, and that the regulatory pathway for these 
protease actions within the synaptic cleft is not known. 
While the cloned chick ARIA does not have the spacer 
domain between the Ig-like and EGF-like domains, the spacer 
domain has been identified in other neuregulin homologs [19-
21]. The functional role of the spacer domain in other mem-
bers of the neuregulin family is not known, but it has been 
proposed that this domain is the site for carbohydrate attach-
ment and may be responsible for glycosaminoglycan binding. 
Recently, various isoforms of ARIA containing a spacer do-
main were also identified in chick muscle (Ng et al., manu-
script submitted). Whether the existence of a spacer domain at 
ARIA sequence will affect the activity and the cleavage of 
EGF-like fragment is not clear. However, it is possible that 
such a heavy glycosylated spacer domain could regulate the 
susceptibility of ARIA to protease actions at the synaptic 
cleft. 
We report here a procedure for the rapid purification of 
recombinant ARIAgi36-K205-Fc which provides an excellent 
ligand for ARIA receptor identification. Although erbB kin-
ases have been demonstrated to be phosphorylated by the 
application of ARIA in cultured muscle cells, direct evidence 
for the erbB kinases to be the true receptor for ARIA is 
lacking. The true receptor for ARIA could be a homolog of 
erbB kinase, and the activation of ARIA receptor requires 
heterodimerization with erbB kinase(s) in the postsynaptic 
muscle membranes [17]. ARIAsi36-K205-Fc possesses several 
advantages in receptor binding and in receptor cross-linkage 
analysis. The fusion protein could be purified with relative 
ease and is stable for weeks at cold temperature. Detection 
of the ligand could be accomplished using protein A that is 
highly specific and commercially available in many conjugated 
forms. The utilization of the EGF-like fragment for our bind-
ing assay would obviate the problem of interference by mol-
ecules that interact with other parts of ARIA, such as the Ig-
like domain. Moreover, the specificity of the cross-linked pro-
tein could include an excess amount of untagged 
ARIAsi36-K205 as the displacement ligand. Using this ligand, 
researchers at our laboratory are searching for different bind-
ing components of ARIA in many chick tissues. 
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